Please login to the form below

Not currently logged in
Email:
Password:

Amy O'Connor

This page shows the latest Amy O'Connor news and features for those working in and with pharma, biotech and healthcare.

Destination Discovery - Lilly's answer to Boehringer's Syrum?

Destination Discovery - Lilly's answer to Boehringer's Syrum?

The thinking behind Lilly's game is to highlight the pharma industry's research and regulatory efforts, explained Amy O'Connor, senior director - digital and social media communications.  .

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • 90TEN bolsters senior management team 90TEN bolsters senior management team

    90TEN’s creative services team has also been strengthened by the promotion of James Duggan (pictured top middle) to director, creative services at 90TEN Medical and Amy O’Connor (pictured bottom ... Both Duggan and O’Connor will take on

  • 90Ten Healthcare boosts PR team 90Ten Healthcare boosts PR team

    Claire Long, Amy O’Connor and Danielle Guildford-Sharp join. Healthcare consultancy 90Ten Healthcare has boosted its public relations team with the appointments of Claire Long, Amy O'Connor and Danielle ... Meanwhile, O'Connor (pictured left) and

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics